Another human TRIM homolog, TRIM29, has been directly implicated in STING modulation as well as gastric cancer outcomes;66–68 thus, we also analyzed expression levels of TRIM29 within the patient cohort and demonstrated significantly higher levels of expression in patient samples that harbored inflammation or cancer (Figure 10(d)). Here, TRIM29 is linked to gastric cancer.